XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Xenon Pharmaceuticals Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$35.08+1.59 (+4.75%)
Close on Oct 19, 2026
- Market cap
- $3.49B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Xenon Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 22, 2026 | Apr 22, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Feb 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2025 | Dec 1, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 5, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2025 | Jan 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2024 | Jun 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 26, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2024 | Apr 19, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 8, 2024 | Mar 8, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 29, 2024 | SEC EDGAR |